miPlan: A Trial of miPlan Intervention vs. Standard of Care

Not Applicable

Completed

• Conditions: Unintended Pregnancy
• Interventions: Behavioral: miPlan intervention

• Registration Number: NCT02396602
• Lead Sponsor: University of Chicago

Brief Summary

Using our experience in digital media, behavior theory, client-centered interventions, and family planning, we have prototyped a digital application ("app")-miPlan-to be used in the clinic waiting room prior to a contraceptive visit. The goal of this research is to refine the app and conduct a randomized controlled trial of the miPlan intervention vs. standard care. The aim of this study is to understand miPlan's impact. The primary outcome is LARC uptake at clinic discharge. The secondary outcomes are contraceptive use at discharge, self-efficacy and decisional balance for highly effective contraception post-app use, contraceptive satisfaction, and intention to continue method use. The research will consist of baseline activities as well as a three-month follow-up call.

Detailed Description

Using our experience in digital media, behavior theory, client-centered interventions, and family planning, we have prototyped a digital application ("app")-miPlan-to be used in the clinic waiting room prior to a contraceptive visit. The goal of this research is to refine the app and conduct a randomized controlled trial of the miPlan intervention vs. standard care contraceptive counseling. The aim of this study is to understand miPlan's impact in terms of contraceptive knowledge, intentions and behaviors. The primary outcome is LARC uptake, which will be measured via chart review at clinic discharge, i.e. immediately following a patient's family planning visit. The secondary outcomes are contraceptive use at discharge (measured via chart review immediately following patient's family planning visit), self-efficacy and decisional balance (both measured via adapted validated scales for each) for highly effective contraception post-app use (measured immediately following intervention and prior to contraceptive counseling session), contraceptive satisfaction (measured at 3 months post baseline), and intention to continue method use (measured at 3 months post baseline). The research will consist of baseline activities as well as a three-month follow-up call.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2015-02
• Study First Submitted: 2015-02-16
• Study First Submitted QC: 2015-03-17
• Study First Posted: 2015-03-24
• Primary Completion: 2016-06
• Status Verified: 2016-08
• Study Completion: 2016-08
• Last Update Submitted: 2016-08-24
• Last Update Posted: 2016-08-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 225

Inclusion Criteria

• African American or Latina female and sexually active with a male partner(s) within the past 6 months,
• age 15 to 29 years
• present for contraception initiation
• English speaking

Read More

Exclusion Criteria

• not currently pregnant or intending pregnancy within the next 6 months
• and not currently using LARC
• not highly intending LARC at enrollment

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	miPlan intervention	After completing baseline the baseline questionnaire, women randomized to the intervention group will receive an iPad, along with a brief tutorial on iPad navigation, and use the miPlan app for up to 15 minutes. They will complete a post-intervention survey before proceeding to standard of care contraceptive counseling.

Primary Outcome Measures

Name	Time	Method
LARC uptake	at time of intervention (baseline (0 weeks)	uptake of the implant or IUD at time of intervention (measured via contraceptive method choice and delivery by checkbox)

Secondary Outcome Measures

Name	Time	Method
change in self-efficacy for contraception at 12 weeks	baseline (0 weeks) and 12 weeks	change in self efficacy for contraceptive method use (measured via validated 5-item attitudinal scale by Galavotti et al 1995) from baseline to 12 weeks
contraceptive use	at time of intervention (baseline (0 weeks))	use of contraceptive methods at time of intervention (measured via contraceptive method choice and delivery by checkbox)
change in decisional balance for highly effective methods at 12 weeks	baseline (0 weeks) and 12 weeks	change in decisional balance for highly effective methods (measured via validated 10-item attitudinal scale by Galavotti et al 1995) from baseline to 12 weeks
contraceptive satisfaction	12 weeks post-enrollment	satisfaction with contraceptive method choice (measured by 4-point Likert scale)
intention to continue method use	12 weeks post enrollment	intention to continue contraceptive method use (measured dichotomously)

Trial Locations

Locations (1)

Planned Parenthood Illinois, Englewood Health Center; 🇺🇸 Chicago, Illinois, United States